Welcome to our dedicated page for WW International SEC filings (Ticker: WW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for WW International, Inc. (WeightWatchers), historically associated with the ticker WW and, during its Chapter 11 process, WGHTQ on OTC Markets. These filings offer detailed information on the company’s financial condition, capital structure, governance, and material events that shape its weight management and clinical businesses.
WeightWatchers uses periodic reports such as annual reports on Form 10‑K and quarterly reports on Form 10‑Q to disclose its subscription-based business model, including Behavioral and Clinical Subscription Revenues, Other Revenues, and metrics like Incoming Subscribers, End of Period Subscribers, and Monthly Subscription Revenues Per Average Subscriber. These documents explain how the company defines its Behavioral and Clinical businesses and how management evaluates subscriber and revenue trends.
Current reports on Form 8‑K, several of which are referenced here, describe material developments such as quarterly earnings releases, leadership changes, and the company’s 2025 financial reorganization. A June 25, 2025 Form 8‑K outlines the confirmation and effectiveness of the prepackaged Chapter 11 plan of reorganization, the discharge of prepetition credit facilities and senior secured notes, the issuance of new common stock, and the cancellation of prior equity securities. Subsequent 8‑Ks furnish earnings press releases and shareholder letters for fiscal quarters following emergence.
A Form 25 filed by Nasdaq Stock Market LLC on July 3, 2025 documents the removal from listing and registration of the company’s old common stock, which was canceled in the bankruptcy proceeding. Together, these filings trace the evolution of WeightWatchers’ capital structure, listing status, and governance framework.
On Stock Titan, SEC documents for WW are supplemented with AI-powered summaries that highlight key points from long filings, helping readers understand complex topics such as fresh start accounting, new credit agreements, changes in control, and definitions of non‑GAAP metrics like Adjusted EBITDA. Users can also review insider and governance-related disclosures in Forms 3, 4, and 5 when available, alongside proxy materials that address board composition and director compensation. This combination of real-time EDGAR updates and AI explanations makes it easier to follow how regulatory disclosures relate to WeightWatchers’ behavioral and clinical weight health strategy.
WW International furnished a press release and a shareholder letter announcing financial results for its fiscal quarter ended June 30, 2025. The filing lists those materials as Exhibits 99.1 and 99.2 and the cover page in Inline XBRL as Exhibit 104. The company states the materials are being furnished, not "filed," and says they will not be incorporated by reference into registration statements except by specific reference.
WW International, Inc. (Nasdaq: WW) filed an 8-K on 7 July 2025 announcing a governance change. The Board unanimously elected Fallon O’Connor-Brooks as an independent director effective 8 July 2025, with a term running until the 2026 annual meeting. Concurrently, the Board created a new Strategy and Finance Committee (effective 1 July 2025) and named Ms. O’Connor its first member.
Compensation mirrors the company’s standard package for non-employee directors:
- $90,000 annual cash retainer, paid quarterly
- Additional $10,000 annual cash fee for SF Committee service
- Proration applies for the remainder of fiscal 2025
- The Board expects to introduce a new equity grant program for non-employee directors later in fiscal 2025
No arrangements or related-party transactions were disclosed, and Nasdaq independence requirements are met. The filing also furnishes a press release (Exhibit 99.1) regarding the appointment. No financial results, transactions, or operational updates were included.